title: [Gardasil®-induced erythema nodosum].
abstract: Erythema nodosum is a panniculitis occurring more frequently in young women. We report a 16-year-old woman who presented with erythema nodosum that occurred following Gardasil® administration (vaccine against HPV types 6, 11, 16 and 18) and that is proposed to young female. This adverse effect is not a contraindication to the HPV vaccination because its benefit against the oncogene risk of Papillomavirus is documented.
authors: Service de dermatologie, CHU Dupuytren, 2 avenue Martin-Luther-King, Limoges, France.
authors: C
authors: C
authors: Longueville
authors: V
authors: V
authors: Doffoel-Hantz
authors: S
authors: S
authors: Hantz
authors: N
authors: N
authors: Souyri
authors: Y
authors: Y
authors: Nouaille
authors: C
authors: C
authors: Bédane
authors: A
authors: A
authors: Sparsa
mesh_terms: D000293:Adolescent; D004893:Erythema Nodosum / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D053918:Papillomavirus Vaccines / Q000009:adverse effects*
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines